{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:21:15Z","timestamp":1780374075942,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781071617519","type":"print"},{"value":"9781071617526","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1752-6_32","type":"book-chapter","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T21:02:28Z","timestamp":1636664548000},"page":"515-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of CPP-Based Methods for Delivery of miRNAs into the Skin and Airways: Lessons from Cell Culture and Mouse Models"],"prefix":"10.1007","author":[{"given":"Anet","family":"Laanesoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapilraj","family":"Periyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Pooga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rebane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"issue":"5871","key":"32_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1126\/science.1152326","volume":"319","author":"EV Makeyev","year":"2008","unstructured":"Makeyev EV, Maniatis T (2008) Multilevel regulation of gene expression by microRNAs. Science 319(5871):1789\u20131790","journal-title":"Science"},{"issue":"6246","key":"32_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1126\/science.1260969","volume":"349","author":"E Izaurralde","year":"2015","unstructured":"Izaurralde E (2015) GENE REGULATION. Breakers and blockers-miRNAs at work. Science 349(6246):380\u2013382","journal-title":"Science"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","volume":"30","author":"RM O\u2019Connell","year":"2012","unstructured":"O\u2019Connell RM, Rao DS, Baltimore D (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30:295\u2013312","journal-title":"Annu Rev Immunol"},{"issue":"33","key":"32_CR4","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD et al (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103(33):12481\u201312486","journal-title":"Proc Natl Acad Sci U S A"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13601-019-0301-8","volume":"9","author":"A Kivihall","year":"2019","unstructured":"Kivihall A et al (2019) Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration. Clin Transl Allergy 9:62","journal-title":"Clin Transl Allergy"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-11-71","volume":"11","author":"SG Crone","year":"2012","unstructured":"Crone SG et al (2012) microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 11:71","journal-title":"Mol Cancer"},{"issue":"4","key":"32_CR7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jaci.2014.05.022","volume":"134","author":"A Rebane","year":"2014","unstructured":"Rebane A et al (2014) MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 134(4):836\u2013847. e11","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"32_CR8","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/jid.2014.89","volume":"134","author":"F Meisgen","year":"2014","unstructured":"Meisgen F et al (2014) MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. J Invest Dermatol 134(7):1931\u20131940","journal-title":"J Invest Dermatol"},{"issue":"3","key":"32_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203\u2013222","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"32_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu B et al (2020) Therapeutic siRNA: state of the art. Signal Transduct Target Ther 5(1):101","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"32_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL et al (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368(18):1685\u20131694","journal-title":"N Engl J Med"},{"issue":"3","key":"32_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/mt.2011.284","volume":"20","author":"H Margus","year":"2012","unstructured":"Margus H, Padari K, Pooga M (2012) Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther 20(3):525\u2013533","journal-title":"Mol Ther"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jconrel.2016.06.006","volume":"235","author":"E Urgard","year":"2016","unstructured":"Urgard E et al (2016) Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis. J Control Release 235:195\u2013204","journal-title":"J Control Release"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"120316","DOI":"10.1016\/j.biomaterials.2020.120316","volume":"262","author":"JM Gemma Carreras-Badosa","year":"2020","unstructured":"Gemma Carreras-Badosa JM, Periyasamy K, Urgard E, Padari K, Vaher H, Tserel L, Gestin M, Kisand K, Arukuusk P, Lou C, Langel \u00dc, Wengel J, Pooga M, Rebane A (2020) NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation. Biomaterials 262:120316","journal-title":"Biomaterials"},{"issue":"1","key":"32_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1021\/mp3003557","volume":"10","author":"KL Veiman","year":"2013","unstructured":"Veiman KL et al (2013) PepFect14 peptide vector for efficient gene delivery in cell cultures. Mol Pharm 10(1):199\u2013210","journal-title":"Mol Pharm"},{"issue":"12","key":"32_CR16","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1093\/nar\/gkr072","volume":"39","author":"K Ezzat","year":"2011","unstructured":"Ezzat K et al (2011) PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Res 39(12):5284\u20135298","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"32_CR17","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1039\/C9BM00688E","volume":"7","author":"L Porosk","year":"2019","unstructured":"Porosk L et al (2019) Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP. Biomater Sci 7(10):4363\u20134374","journal-title":"Biomater Sci"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2016.08.007","volume":"242","author":"K Basler","year":"2016","unstructured":"Basler K et al (2016) The role of tight junctions in skin barrier function and dermal absorption. J Control Release 242:105\u2013118","journal-title":"J Control Release"},{"issue":"5","key":"32_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri3646","volume":"14","author":"M Pasparakis","year":"2014","unstructured":"Pasparakis M, Haase I, Nestle FO (2014) Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 14(5):289\u2013301","journal-title":"Nat Rev Immunol"},{"key":"32_CR20","doi-asserted-by":"crossref","unstructured":"Laanesoo A et al (2021) Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation. Clin Transl Med. 11:e427","DOI":"10.1002\/ctm2.427"},{"issue":"11","key":"32_CR21","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1111\/all.13849","volume":"74","author":"H Vaher","year":"2019","unstructured":"Vaher H et al (2019) miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation. Allergy 74(11):2146\u20132156","journal-title":"Allergy"},{"issue":"1","key":"32_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/exd.14049","volume":"29","author":"H Vaher","year":"2020","unstructured":"Vaher H et al (2020) SERPINB2 and miR-146a\/b are coordinately regulated and act in the suppression of psoriasis-associated inflammatory responses in keratinocytes. Exp Dermatol 29(1):51\u201360","journal-title":"Exp Dermatol"},{"issue":"4","key":"32_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109\u20131118","journal-title":"J Exp Med"},{"issue":"1","key":"32_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.immuni.2019.05.014","volume":"51","author":"CA Tibbitt","year":"2019","unstructured":"Tibbitt CA et al (2019) Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells. Immunity 51(1):169\u2013184","journal-title":"Immunity"}],"container-title":["Methods in Molecular Biology","Cell Penetrating Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1752-6_32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T21:10:53Z","timestamp":1636665053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1752-6_32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"ISBN":["9781071617519","9781071617526"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1752-6_32","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"assertion":[{"value":"12 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}